(Q35103404)

6 August 2017

Akkermansia muciniphila: a novel target controlling obesity, type 2 diabetes and inflammation? (English)

1 reference

6 August 2017

1 reference

Akkermansia muciniphila

object named as

Akkermansia muciniphila

1 reference

1

1 reference

6 August 2017

Amandine Everard

2

1 reference

PubMed ID

24572104

6 August 2017

language of work or name

French

0 references

publication date

24 February 2014

1 reference

6 August 2017

1 reference

6 August 2017

30

1 reference

6 August 2017

2

1 reference

6 August 2017

125-127

1 reference

Gut microbiota, enteroendocrine functions and metabolism

6 August 2017

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20143002003

The gut microbiota and obesity: from correlation to causality

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20143002003

Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20143002003

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20143002003

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20143002003

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20143002003

Richness of human gut microbiome correlates with metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20143002003

Human gut microbiota changes reveal the progression of glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20143002003

Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20143002003

10.1051/MEDSCI/20143002003

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

0 references

1 reference

PubMed ID

24572104